# How Long Does Spike Protein Stay in Your Body? What Studies Found

> How long does spike protein stay in your body? A study-by-study timeline after infection and vaccination, with sample sizes, methods and limits.

Canonical: https://amyloid-test.com/resources/how-long-spike-protein-stays/
Last updated: 2026-11-22
Author: Tim Ottowitz
Evidence level: review

**Short answer:** How long does spike protein stay in your body? A 2022 CDC fact sheet said up to a few weeks. Small research studies report spike or spike fragments for longer in some people: 60 days in lymph nodes after vaccination, 187 days in one blood study, and up to 12 months after infection. How common that is, and whether it causes symptoms, isn't known.

## Key takeaways

- The CDC's 2022 fact sheet says vaccine mRNA is cleared within a few days and spike protein may stay up to a few weeks.
- Several small studies report longer detection in some people: up to 60 days in lymph nodes, 187 days in blood after vaccination, and 12 months in blood after infection.
- A Yale preprint (not peer reviewed) found detectable spike S1 in about a third of both people with post-vaccination syndrome and healthy controls, with higher levels in the affected group.
- Spike antibodies are not spike protein: antibodies are the immune memory a normal response leaves behind, and many tests sold as spike tests measure them.
- Nobody knows how common persistence is or whether it causes symptoms, and no commercial test has been validated to measure it.

How long does spike protein stay in your body? A 2022 CDC fact sheet said up to a few weeks, but a handful of small studies have found spike or spike fragments for months in some people, and one preprint, not yet peer reviewed, reported S1 up to 709 days after the last known vaccination or infection. Below is each study with its sample size, method and time point, split into after vaccination and after infection, so you can judge how far the findings reach.

## What does the official guidance say?

A CDC fact sheet on mRNA vaccines (archived, updated July 2022) says cells break down the mRNA and get rid of it within a few days. It adds that scientists estimate the spike protein, like other proteins the body makes, may stay in the body up to a few weeks. The CDC's current vaccine basics page says the cells break down the mRNA after the protein piece is made, and gives no duration.

That's the mainstream position. The studies below are the reason some researchers think it may not hold for everyone.

## The study-by-study timeline

"Longest detection" is the latest time point at which the authors report a positive result, not a typical value. Every study here is small.

| Study | Who | Method | Longest detection | Limits |
|---|---|---|---|---|
| Ogata et al., Clin Infect Dis 2022 (vaccination) | 13 healthcare workers given two doses of mRNA-1273, no known prior COVID-19 | Simoa assay on plasma, 10 to 13 samples each to 28 days after dose 2 | S1 in 11 of 13 from day 1, undetectable in all by day 14; full spike in 3 of 13 around day 15; none after dose 2 bar one person for a day | Very small pilot; the paper reports clearance, not long-term persistence |
| Röltgen et al., Cell 2022 (vaccination) | 7 lymph node biopsies; plasma from Pfizer-BioNTech vaccinees | Immunostaining of node tissue; plasma antigen assay | Spike in lymph node germinal centres up to 60 days after dose 2; in plasma, 63% positive at day 7 after dose 1 | Only 7 biopsies, so no estimate of how common this is |
| Brogna et al., Proteomics Clin Appl 2023 (vaccination) | 20 vaccinated, 20 unvaccinated (also tested after catching COVID-19) | Mass spectrometry on 2 µL of capillary blood | Vaccine-specific fragment in 50% of samples, 69 to 187 days after vaccination | Short rapid communication; authors say larger studies are needed |
| Patterson et al., Hum Vaccin Immunother 2025 (vaccination) | 50 people with symptoms after vaccination, 26 vaccinated controls | Flow cytometry for S1 in monocytes, mass spectrometry in 5 | S1 in monocytes up to 245 days (12 patients screened) | S1 in 1 of 10 controls; prior infection couldn't be fully excluded |
| Bhattacharjee et al., medRxiv 2025 (vaccination, preprint) | 42 with post-vaccination syndrome, 22 vaccinated controls; median 585 vs 199 days since last vaccine dose | SPEAR immunoassay for S1 in plasma | Detectable S1 from 26 to 709 days after the last known exposure (vaccination or infection) | Preprint, not peer reviewed; cross-sectional; S1 in 35.7% of cases and 31.8% of controls; past infection can't be fully ruled out |
| Swank et al., Clin Infect Dis 2023 (infection) | 63 people: 37 with PASC, rest COVID-19 | Single-molecule array on plasma | Spike in about 60% of PASC patients, up to 12 months | Retrospective pilot; unmatched comparison group |
| Patterson et al., Front Immunol 2022 (infection) | 46 people: 26 with PASC, 11 severe COVID-19, 1 asymptomatic, 8 healthy controls | Flow cytometry of monocytes, mass spectrometry on sorted cells | S1 inside monocytes up to 15 months | Cell-based; no viral sequence found that explains the protein; enrolment figure corrected to 46 in 2026 |

## What did studies find after vaccination?

Ogata and colleagues tested plasma from 13 healthcare workers through two doses of mRNA-1273 with an ultra-sensitive Simoa assay. S1, a piece of spike, appeared in 11 of 13 from day 1, peaked on average at day 5 and was undetectable in everyone by day 14.

Röltgen and colleagues at Stanford biopsied armpit lymph nodes from seven vaccinated people 7 to 60 days after the second dose. Vaccine mRNA and spike antigen sat in germinal centres, the nodes' antibody-training zones, with spike still present at day 60. In plasma, spike was found in 96% of vaccinees at days 1 to 2 and 63% at day 7 after the first dose.

Lymph node spike is a local finding. It doesn't show spike circulating for 60 days.

Brogna and colleagues used a different approach. A double-proline change in the vaccine spike removes a trypsin cut site, so mass spectrometry can tell the vaccine fragment from the natural virus spike. They found it in 50% of the vaccinated group's samples, from 69 to 187 days after vaccination, and in none of the unvaccinated controls. The paper is a short rapid communication, and its authors say their hypotheses need more and larger studies.

## What did studies find after infection?

Swank and colleagues measured plasma from 63 people. Spike turned up in about 60% of the 37 people with post-acute sequelae of COVID-19 (PASC), at multiple time points from 2 to 12 months. It wasn't found in the COVID-19 patients, who were mostly sampled in the first month. Because the groups differ in timing, the comparison is weak.

Patterson and colleagues, studying 46 people, found S1 inside CD16+ monocytes, a type of immune cell, in severe COVID-19 and PASC patients out to 15 months. That's a cell-bound signal, so it says little about free spike in plasma. The group found no viral sequence that explained the protein.

## Is spike protein the same as spike antibodies?

No, and mixing them up causes most of the confusion. Spike antibodies are made by your immune system after infection or vaccination. The CDC says vaccination leaves the body with memory B and T cells that remember how to fight the virus. In Röltgen's cohort of 59 vaccine recipients, spike IgG peaked at day 28 and had fallen about 20-fold by 9 months. A positive antibody test shows exposure, not leftover spike.

Our guide to [spike antibody vs antigen testing](https://amyloid-test.com/resources/spike-protein-persistence-testing/) and the [spike protein test overview](https://amyloid-test.com/resources/spike-protein-test/) cover what each assay measures.

## What isn't known?

How common persistence is, for one. The Yale preprint, which hasn't been peer reviewed, found detectable S1 in 35.7% of people with post-vaccination syndrome and 31.8% of controls, with higher levels in the affected group on average. Yale's Akiko Iwasaki said in the university's news release that it isn't known whether the spike level causes the symptoms, and some people with the syndrome had no measurable spike.

Whether it causes symptoms is the second gap. No study above shows that persistent spike drives illness, and the infection and vaccination cohorts differ in assays and timing. Our guides to [post-vaccination syndrome](https://amyloid-test.com/resources/post-vaccination-syndrome-symptoms/) and [spike amyloid fibrils and fibrinolysis](https://amyloid-test.com/resources/spike-protein-amyloid-fibrils-fibrinolysis/) cover the proposed mechanisms.

## Can you test for spike protein persistence?

Not in a validated way. The assays above are research tools run in specialised labs, with no reference range. To our knowledge no commercial test has been validated to measure spike persistence, so a single result couldn't tell you what's normal.

## Questions to ask your doctor

- Could another, more common cause explain my symptoms, and which standard tests would check for it?
- If I've had antibody or antigen testing, what did it measure, and would the result change my care?
- Is there a research study near me that studies post-vaccination or post-COVID symptoms?
- Which symptoms should send me for urgent care?

Don't start, stop or combine any medicine or supplement because of a spike claim without your clinician's agreement. Chest pain, severe breathlessness, a swollen painful leg, one-sided weakness or confusion could be a heart attack, clot or stroke: call emergency services.

## Where an at-home test fits

Our at-home [amyloid fibrin test](https://amyloid-test.com/) doesn't measure spike protein. It's a finger-prick dried blood sample stained with Thioflavin T and imaged at a partner laboratory, and the report counts and measures glowing shapes. It isn't a diagnosis, hasn't been validated against the venous platelet-poor-plasma method used in microclot research, and no result is promised to change your care. If you want to look at that side, see how [microclot testing works](https://amyloid-test.com/resources/how-to-test-for-microclots/), the [amyloid fibrin test guide](https://amyloid-test.com/resources/amyloid-fibrin-test/) and our definition of [microclots](https://amyloid-test.com/resources/what-are-microclots/), or compare the [at-home microclot test](https://amyloid-test.com/microclot-test/).

## FAQ

### How long does spike protein last after the COVID vaccine?

A 2022 CDC fact sheet said the body clears vaccine mRNA within a few days and that spike protein may stay up to a few weeks. Research studies report detection for longer in some people: spike in lymph nodes up to 60 days after the second dose, and a vaccine-specific spike fragment in blood up to 187 days in a 20-person study. How often this happens is unknown.

### How long does spike protein stay after a COVID infection?

In a 2023 pilot study of 63 people, six COVID-19 patients followed over time had high antigen soon after diagnosis that dropped below the detection limit quickly. Spike was found in about 60% of people with post-acute COVID sequelae, up to 12 months after diagnosis, but not in the COVID-19 comparison group, who were mostly sampled within a month.

### Does spike protein go away on its own?

For most people the evidence suggests it does: in an early study of 13 vaccinated healthcare workers, spike antigen was undetectable in plasma by day 14 as antibodies appeared. In some people, including some with long-lasting symptoms, researchers have found spike months later. We found no long follow-up study showing whether and how it clears in those people.

### Is a spike antibody test the same as a spike protein test?

No. Antibodies are made by your immune system in response to spike, whether from infection or vaccination, and a positive result is normal immune memory. A spike protein (antigen) test looks for the protein itself. Many tests sold as spike tests measure antibodies, and a high antibody level doesn't mean spike protein is still present.

### Can I get tested for how long spike protein stays in my system?

Not in a validated way. The studies used research assays such as ultra-sensitive immunoassays and mass spectrometry, run in specialised labs. To our knowledge no commercial test has been validated for spike persistence, and there is no reference range that says what a result means for your health. Speak with a clinician before paying for any such test.

## Sources

- [Understanding mRNA COVID-19 Vaccines (archived page, updated July 15, 2022)](https://stacks.cdc.gov/view/cdc/119428) (Centers for Disease Control and Prevention, 2022)
- [COVID-19 Vaccine Basics](https://www.cdc.gov/covid/vaccines/how-they-work.html) (Centers for Disease Control and Prevention, 2024)
- [Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients](https://doi.org/10.1093/cid/ciab465) (Clinical Infectious Diseases, 2022)
- [Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination](https://doi.org/10.1016/j.cell.2022.01.018) (Cell, 2022)
- [Detection of recombinant Spike protein in the blood of individuals vaccinated against SARS-CoV-2: Possible molecular mechanisms](https://doi.org/10.1002/prca.202300048) (Proteomics - Clinical Applications, 2023)
- [Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals](https://doi.org/10.1080/21645515.2025.2494934) (Human Vaccines & Immunotherapeutics, 2025)
- [Immunological and Antigenic Signatures Associated with Chronic Illnesses after COVID-19 Vaccination (preprint, not peer reviewed)](https://doi.org/10.1101/2025.02.18.25322379) (medRxiv, 2025)
- [Immune markers of post-vaccination syndrome indicate future research directions](https://news.yale.edu/2025/02/19/immune-markers-post-vaccination-syndrome-indicate-future-research-directions) (Yale News, 2025)
- [Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae](https://doi.org/10.1093/cid/ciac722) (Clinical Infectious Diseases, 2023)
- [Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection](https://doi.org/10.3389/fimmu.2021.746021) (Frontiers in Immunology, 2022)

## Related

- [Spike Protein Test: Antibody, Antigen, and Downstream Testing](https://amyloid-test.com/resources/spike-protein-test/)
- [Spike Protein Amyloid Fibrils: How Spike685 Makes Clots Resist Lysis](https://amyloid-test.com/resources/spike-protein-amyloid-fibrils-fibrinolysis/)
- [Amyloid Fibril Test: Methods Used to Detect Amyloid Fibrils](https://amyloid-test.com/resources/amyloid-fibril-test/)
